The DOI matches its Crossref record.
Hypertriglyceridemic Waist: A Marker of the Atherogenic Metabolic Triad (Hyperinsulinemia; Hyperapolipoprotein B; Small, Dense LDL) in Men?
Abstract
Background —The present study tested the hypothesis that simple variables, such as waist circumference and fasting plasma triglyceride (TG) concentrations, could be used as screening tools for the identification of men characterized by a metabolic triad of nontraditional risk factors (elevated insulin and apolipoprotein [apo] B and small, dense LDL particles). Methods and Results —Results of the metabolic study (study 1) conducted on 185 healthy men indicate that a large proportion (>80%) of men with waist circumference values ≥90 cm and with elevated TG levels (≥2.0 mmol/L) were characterized by the atherogenic metabolic triad. Validation of the model in an angiographic study (study 2) on a sample of 287 men with and without coronary artery disease (CAD) revealed that only men with both elevated waist and TG levels were at increased risk of CAD (odds ratio of 3.6, P <0.03) compared with men with low waist and TG levels. Conclusions —It is suggested that the simultaneous measurement and interpretation of waist circumference and fasting TG could be used as inexpensive screening tools to identify men characterized by the atherogenic metabolic triad (hyperinsulinemia, elevated apo B, small, dense LDL) and at high risk for CAD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adding biochemical markers, such as plasma triglyceride levels, to the measurement of waist circumference—a phenotype described as hypertriglyceridaemic waist—has been suggested as a useful method for identification of individuals with excess visceral adipose tissue and ectopic fat.51”
From Definition and diagnostic criteria of clinical obesity (2025) · cites this paper as [51]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 28
- 10.1073/pnas.77.1.604 · DOI
- 10.1161/circ.94.3.273 · DOI
- 10.1136/hrt.71.3.293 · DOI
- 10.1056/NEJM199604113341504 · DOI · Paper page
- 10.1161/atv91.12.2.1543692 · DOI
- 10.1161/circ.95.1.69 · DOI
- 10.1001/jama.279.24.1955 · DOI
- 10.2337/diab.41.7.826 · DOI
- 10.1016/0002-9149(94)90676-9 · DOI
- 10.2337/diacare.19.6.629 · DOI · Paper page
- 10.1093/clinchem/28.10.2077 · DOI
- 10.1093/clinchem/20.4.470 · DOI
- 10.1172/JCI103182 · DOI
- 10.1016/0009-8981(60)90075-9 · DOI
- 10.1016/0003-2697(66)90246-6 · DOI
- 10.1016/0026-0495(87)90183-1 · DOI
- 10.1210/jcem-33-5-732 · DOI
- Standardization of anthropometric measurements. In: Lohman T Roche A Martorel R eds. The Airlie (VA) Consensus Conference. Champaign Ill: Human Kinetics; 1988:39–80.
- 10.1079/BJN19890104 · DOI
- 10.1016/S0002-9149(98)00328-2 · DOI
- 10.1161/circ.97.9.871 · DOI
- 10.1016/0009-8981(87)90188-4 · DOI
- 10.1093/clinchem/28.6.1379 · DOI
- 10.1093/clinchem/18.6.499 · DOI · Paper page
- 10.1161/atv91.12.11.1420088 · DOI
- 10.1161/01.CIR.85.1.37 · DOI · Paper page
- 10.1079/NRR19930010 · DOI
- 10.1016/S0140-6736(94)90814-1 · DOI
Cited by
Sorted by citations
Items 201–300 of 819
Tappy, L. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.12.022 · Cited by 80
Ethnic‐Specific Differences in Abdominal Subcutaneous Adipose Tissue Compartments
Kohli, S., Sniderman, A. D., Tchernof, A., & Lear, S. A. (2010) · Obesity · doi:10.1038/oby.2010.94 · Cited by 61
Self-citationA 16-week fenofibrate treatment increases LDL particle size in type IIA dyslipidemic patients.
Lemieux, I., Laperrière, L., Džavík, V., Tremblay, G., Bourgeois, J., & Despres, J. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00711-0 · Cited by 63
“On the basis of previously published criteria to identify carriers of the triad [30], we have quantified the prevalence of patients with small, dense LDL particles or with the atherogenic metabolic triad at baseline and after the 16-week treatment with fenofibrate or pravastatin.”
Self-citationOudin, C., Auquier, P., Bertrand, Y., Contet, A., Kanold, J., Sirvent, N., Thouvenin, S., Tabone, M.-D., Lutz, P., Ducassou, S., et al. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.167 · Cited by 69
Insulin Resistance, Impaired Postprandial Lipid Metabolism and Abdominal Obesity
Frayn, K. N. (2002) · Medical Principles and Practice · doi:10.1159/000066414 · Cited by 49
O'Donovan, G., Owen, A., Kearney, E. M., Jones, D. W., Nevill, A. M., Woolf-May, K., & Bird, S. R. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803004 · Cited by 61
Incidence of type 2 diabetes in two Indigenous Australian populations: a 6‐year follow‐up study
McDermott, R., Li, M., & Campbell, S. (2010) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2010.tb03636.x · Cited by 61
Leptin and Metabolic Syndrome in Obese and Non-Obese Children
Moreno, L., Pineda, I., Rodríguez, G., Fleta, J., Giner, A., Juste, M., Sarría, A., & Bueno, M. (2002) · Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · doi:10.1055/s-2002-33472 · Cited by 61
Arsenault, B. J., Pelletier-Beaumont, E., Alméras, N., Tremblay, A., Poirier, P., Bergeron, J., & Després, J.-P. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.07.010 · Cited by 58
Self-citationKaler, S. N., Ralph-Campbell, K., Pohar, S., King, M., Laboucan, C. R., & Toth, E. (2006) · International Journal of Circumpolar Health · doi:10.3402/ijch.v65i5.18139 · Cited by 60
Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis
Tkáč, I. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.03.002 · Cited by 54
Cardiovascular risk factors in males with hypertriglycemic waist (Tehran Lipid and Glucose Study)
Solati, M., Ghanbarian, A., Rahmani, M., Sarbazi, N., Allahverdian, S., & Azizi, F. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802582 · Cited by 60
Wang, X.-N., Ye, P., Cao, R., Yang, X., Xiao, W., Zhang, Y., Bai, Y.-Y., & Wu, H.-M. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0266-8 · Cited by 59
“First, insulin resistance, which accompanies abdominal obesity, has vascular effects through associated hyperinsulinaemia and increased glycaemia [40, 41].”
BackgroundAlavian, S., Motlagh, M., Ardalan, G., Motaghian, M., Davarpanah, A., & Kelishadi, R. (2007) · Journal of Tropical Pediatrics · doi:10.1093/tropej/fmm105 · Cited by 59
Blackburn, P., Lemieux, I., Lamarche, B., Bergeron, J., Perron, P., Tremblay, G., Gaudet, D., & Després, J. (2011) · Metabolism · doi:10.1016/j.metabol.2011.05.017 · Cited by 64
Self-citationWang, B., Zhang, M., Liu, Y., Sun, X., Zhang, L., Wang, C., Li, L., Ren, Y., Han, C., Zhao, Y., et al. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12642 · Cited by 62
Schinzari, F., Iantorno, M., Campia, U., Mores, N., Rovella, V., Tesauro, M., Daniele, N. D., & Cardillo, C. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00278.2015 · Cited by 56
Visceral adiposity and risk of coronary heart disease in relatively lean Chinese adults
Zhang, X.-L., Shu, X., Li, H.-L., Yang, G., Xiang, Y.-B., Cai, Q., Ji, B., Gao, Y.-T., & Zheng, W. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.275 · Cited by 56
Obesity, Diabetes, the Cardiorenal Syndrome, and Risk for Cancer
Forte, V. A., Pandey, A. K., Abdelmessih, R. M., Forte, G., Whaley‐Connell, A. T., Sowers, J. R., & McFarlane, S. I. (2012) · Cardiorenal Medicine · doi:10.1159/000337314 · Cited by 50
Metabolic syndrome and cardiovascular risk
Alshehri, A. (2010) · Journal of Family and Community Medicine · doi:10.4103/1319-1683.71987 · Cited by 184
Influence of a walking program on the metabolic risk profile of obese postmenopausal women
Roussel, M., Garnier, S., Lemoine, S., Gaubert, I., Charbonnier, L., Auneau, G., & Mauriège, P. (2009) · Menopause · doi:10.1097/gme.0b013e31818d4137 · Cited by 55
From individual risk factors and the metabolic syndrome to global cardiometabolic risk
Després, J., Poirier, P., Bergeron, J., Tremblay, A., Lemieux, I., & Alméras, N. (2008) · European Heart Journal Supplements · doi:10.1093/eurheartj/sum041 · Cited by 49
Self-citationObesity and Cardiovascular Disease
Poirier, P. (2006) · Circulation · doi:10.1161/circulationaha.106.646455 · Cited by 11
Influenza Viruses in Animal Wildlife Populations
Webby, R. J., Webster, R. G., & Richt, J. A. (2007) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-70962-6_4 · Cited by 55
Effects of Modifying Triglycerides and Triglyceride-rich Lipoproteins on Cardiovascular Outcomes
Abdel-Maksoud, M. F., Sazonov, V., Gutkin, S. W., & Hokanson, J. E. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318165e2e7 · Cited by 54
“Therefore, it is conceivable that IDLs and small VLDL can induce foam cell formation in a fashion parallel to oxidatively modified LDL.59,120,123,124 As with LDL, TRLs are also potential substrates for free-radical reactions, and accumulation of peroxidative metabolites of TRLs within the lipid core may also be associ…”
BackgroundInfluentialGazi, I., Filippatos, T., Tsimihodimos, V., Saougos, V. G., Liberopoulos, E., Mikhailidis, D., Tselepis, A., & Elisaf, M. (2006) · Lipids · doi:10.1007/s11745-006-5015-8 · Cited by 54
Kim, S., Kim, H., Min, K.-K., Lee, H., Lee, S.-H., Kim, S., Kim, J. S., & Oh, B. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256257 · Cited by 53
Soresi, M., Noto, D., Cefalù, A., Martini, S., Vigna, G., Fonda, M., Manzato, E., Cattin, L., Fellin, R., Averna, M., et al. (2013) · Acta Diabetologica · doi:10.1007/s00592-012-0406-1 · Cited by 53
What Is “Metabolically Healthy Obesity”?: From Epidemiology to Pathophysiological Insights
Després, J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2081 · Cited by 52
Self-citationMetabolic syndrome by the international diabetes federation definition in Hong Kong Chinese
Ko, G. T. C., Cockram, C. S., Chow, C. C., Yeung, M. W., Chan, W. B., So, W., Chan, N. N., & Chan, J. C. N. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.11.009 · Cited by 47
Increasing high-density lipoprotein cholesterol: an update on fenofibrate
Després, J. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02150-6 · Cited by 49
Self-citationAbdominal Obesity and the Metabolic Syndrome
Després, J., Lemieux, I., & Alméras, N. (2007) · Springer eBooks · doi:10.1007/978-0-387-32164-6_8 · Cited by 288
Self-citationCentral Obesity and the Metabolic Syndrome: Implications for Primary Care Providers
Appel, S. J., Jones, E., & Kennedy‐Malone, L. (2004) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2004.tb00456.x · Cited by 38
“Dyslipidemia Associations between central obesity and elevated triglycerides, as well as between central obesity and reduced levels of the high-density lipoprotein cholesterol (HDL-C), impose a risk profile for cardiovascular disease— related morbidity and mortality (Lemieux et al., 2000).”
BackgroundInfluentialBody Fat Distribution, Adipocyte Size, and Metabolic Characteristics of Nondiabetic Adults
Mundi, M. S., Karpyak, M. V., Koutsari, C., Votruba, S. B., O’Brien, P. C., & Jensen, M. D. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1353 · Cited by 50
Circulating glutamate level as a potential biomarker for abdominal obesity and metabolic risk.
Maltais-Payette, I., Allam‐Ndoul, B., Pérusse, L., Vohl, M., & Tchernof, A. (2019) · NMCD. Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.08.015 · Cited by 50
“0mmol/L for men [15] and WC ≥85cm, TG ≥1.”
Self-citationFalutz, J. (2007) · Nature Clinical Practice Endocrinology &Metabolism · doi:10.1038/ncpendmet0587 · Cited by 50
Wang, Z., Rowley, K., Wang, Z., Piers, L. S., & O’Dea, K. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000220580.34763.fb · Cited by 49
de Graaf, F., Schuijf, J., Scholte, A., Djaberi, R., van Velzen, J. E., Roos, C., Kroft, L., de Roos, A., van der Wall, E. V., Jukema, J. W., et al. (2010) · American Journal of Cardiology · doi:10.1016/j.amjcard.2010.08.015 · Cited by 49
Self-citationDesprés, J., Lemieux, I., Salomon, H., & Delaval, D. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00988.x · Cited by 44
Self-citationRelationship between serum retinol-binding protein 4 and visfatin and the metabolic syndrome
Lin, C., Lai, M.-M., Li, T., Li, C.-I., Liu, C.-S., Chen, C., & Wu, M. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.03.016 · Cited by 33
Robins, S. J. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200312000-00005 · Cited by 47
Historical perspectives of the metabolic syndrome
Oda, E. (2017) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2017.09.002 · Cited by 57
Wang, A.-X., Li, Z.-X., Zhou, Y., Wang, C.-X., Luo, Y.-X., Liu, X.-X., Guo, X.-H., Wu, S.-L., & Zhao, X.-Q. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.03.177 · Cited by 47
Blackett, P. R., & Sanghera, D. K. (2012) · Journal of clinical lipidology · doi:10.1016/j.jacl.2012.04.079 · Cited by 47
The "hypertriglyceridemic waist" phenotype and glucose intolerance in pregnancy
Brisson, D., Perron, P., Guay, S., Gaudet, D., & Bouchard, L. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.100378 · Cited by 44
Self-citationVasudevan, A. R., & Ballantyne, C. M. (2005) · Clinical cornerstone · doi:10.1016/s1098-3597(05)80063-8 · Cited by 43
Chuang, S., Hsu, Y., Chen, R. C.-Y., Liu, W., & Pan, W. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv192 · Cited by 54
Oh, J.-Y., Sung, Y.-O.-A., & Lee, H. (2013) · Diabetic Medicine · doi:10.1111/dme.12052 · Cited by 45
Borel, A., Nazare, J., Smith, J. D., Alméras, N., Tremblay, A., Bergeron, J., Poirier, P., & Després, J. (2011) · Metabolism · doi:10.1016/j.metabol.2011.06.024 · Cited by 41
Self-citationContribution of visceral fat accumulation to carotid intima–media thickness in a Chinese population
Wang, Y., Ma, X.-J., Zhou, M., Zong, W., Zhang, L.-L., Hao, Y.-P., Zhu, J.-A., Xiao, Y., Li, D., Bao, Y., et al. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.222 · Cited by 45
Pollex, R. L., Hanley, A. J., Zinman, B., Harris, S. B., & Hegele, R. A. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803152 · Cited by 46
“Thus, Lemieux et al.(5) showed that two easily determinable clinical measurements, namely waist circumference and fasting plasma triglyceride concentrations – also called the ‘hypertriglyceridemic waist’ (HTGW) phenotype – are a very good surrogate marker for men with the nontraditional atherogenic triad (480% concord…”
BackgroundCouillard, C., Bergeron, N., Pascot, A., Alméras, N., Bergeron, J., Tremblay, A., Prud’homme, D., & Després, J. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.2.311 · Cited by 41
Self-citationBos, G., Dekker, J., & Heine, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.283 · Cited by 45
Hypertriglyceridemic-waist phenotype predicts diabetes: a cohort study in Chinese urban adults
Zhang, M., Gao, Y., Chang, H., Wang, X., Liu, D., Zhu, Z., & Huang, G. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-1081 · Cited by 43
“[10] were the first group to recognize that the HTGW phenotype was associated with increased CVD risk in men.”
BackgroundSerum Insulin and Inflammatory Markers in Overweight Individuals with and without Dyslipidemia
Barter, P. J., McPherson, Y. R., Song, K. S., Kesäniemi, Y. A., Mahley, R. W., Waeber, G., Bersot, T. P., Mooser, V., Waterworth, D. M., & Grundy, S. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2219 · Cited by 46
Deng, H., Hu, P., Li, H.-X., Zhou, H., Wu, X.-Y., Yuan, M.-B., Duan, X.-R., Lao, M.-C., Wu, C.-C., Zheng, M., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01660-z · Cited by 43
“The hypertriglyceridemic-waist phenotype, defined as elevated TG and enlarged WC, was a simple marker of visceral adiposity [15].”
BackgroundCentral Obesity, the Metabolic Syndrome, and Plasminogen Activator Inhibitor‐1 in Young Adults
Appel, S. J., Harrell, J. S., & Davenport, M. L. (2005) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2005.00083.x · Cited by 39
“Central obesity is also at the core of a cluster of disturbances known as the metabolic syndrome (Lemieux et al., 2000), which includes dyslipidemia, impaired fasting glucose (IFG), hyperinsulinemia, and hypertension (Goran, Bergman, Cruz, & Watanabe, 2002; Reaven, Abbasi, & McLaughlin, 2004).”
BackgroundObesity and diabetes: the links and common approaches
Haslam, D. (2010) · Primary Care Diabetes · doi:10.1016/j.pcd.2010.04.002 · Cited by 42
Huang, J., Han, J., Rozi, R., Fu, B., Lu, Z., Liu, J., & Ding, Y. Q. (2024) · Preventive Medicine · doi:10.1016/j.ypmed.2024.107861 · Cited by 48
Metabolic syndrome and its association with morbidity and mortality
Ardern, C. I., & Janssen, I. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h06-099 · Cited by 46
Prevalence of the hypertriglyceridemic waist phenotype in Iranian adolescents.
Esmaillzadeh, A., Mirmiran, P., Azadbakht, L., & Azizi, F. (2005) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2005.08.041 · Cited by 42
Oka, R., Yagi, K., Sakurai, M., Nakamura, K., Nagasawa, S., Miyamoto, S., Nohara, A., Kawashiri, M., Hayashi, K., Takeda, Y., et al. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12294 · Cited by 42
Influence of obesity and insulin resistance on left atrial size in children
Hirschler, V., Acebo, H. L. P., Fernandez, G. B., de Lujan Calcagno, M., Gonzalez, C., & Jadzinsky, M. (2006) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2006.00139.x · Cited by 41
Liu, P. J., Lou, H. P., & Zhu, Y. N. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s259770 · Cited by 47
O'Connor, M., Lind, C., Tang, X.-Y., Gossett, J., Weber, J., Monos, D., & Shaddy, R. (2013) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.12.009 · Cited by 41
Percentile distributions of waist circumference for 7–19‐year‐old Polish children and adolescents
Ostrowska-Nawarycz, L., Krzyżaniak, A., Stawińska-Witoszyńska, B., Krzywińska-Wiewiórowska, M., Szilágyi-Pagowska, I., Kowalska, M., Krzych, Ł. J., & Nawarycz, T. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00694.x · Cited by 44
Targeting abdominal obesity and the metabolic syndrome to manage cardiovascular disease risk
Després, J. (2009) · Heart · doi:10.1136/hrt.2008.151274 · Cited by 38
Self-citationContribution of CB1 blockade to the management of high-risk abdominal obesity
Després, J., Lemieux, I., & Alméras, N. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803278 · Cited by 37
Self-citationTorun, C., Ankarali, H., Castur, L., Uzunlulu, M., Erbakan, A., Akbaş, M. M., Gündüz, N., Doğan, M., & Oğuz, A. (2023) · Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy · doi:10.2147/dmso.s421623 · Cited by 40
“In 2000, Lemieux et al developed the concept of “hypertriglyceridemic waist circumference” which revealed the relationship between triglycerides and waist circumference with visceral adiposity.(11) Based on this, novel indices, including lipid accumulation product (LAP) and visceral adiposity index (VAI), have been cr…”
BackgroundHypertriglyceridemia in Obese Children and Adolescents
Jung, M., & Yoo, E. (2018) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes.2018.27.3.143 · Cited by 40
Kuk, J. L., Rotondi, M. A., Sui, X., Blair, S. N., & Ardern, C. I. (2018) · Clinical Obesity · doi:10.1111/cob.12263 · Cited by 48
“Thus, whether abdominal obesity should be central to risk criteria, such as some metabolic syndrome criteria (35) or the hypertriglyceridemic waist (36), is unclear.”
BackgroundAssociation of Waist-Height Ratio with Diabetes Risk: A 4-Year Longitudinal Retrospective Study
Son, Y., Kim, J., Park, H., Park, S. E., Park, C., Lee, W., Oh, K. W., Park, S., & Rhee, E. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.1.127 · Cited by 38
Metzner, C., Folberth-Vögele, A., Bitterlich, N., Lemperle, M., Schäfer, S., Alteheld, B., Stehle, P., & Siener, R. (2011) · Nutrition and Metabolism · doi:10.1186/1743-7075-8-64 · Cited by 40
Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women.
Palaniappan, L., Kwan, A., Abbasi, F., Lamendola, C., McLaughlin, T., & Reaven, G. (2007) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2007.01.020 · Cited by 40
Spina, E., Scordo, M., Avenoso, A., & Perucca, E. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200102000-00020 · Cited by 40
Hypertriglyceridemic waist phenotype: association with metabolic abnormalities in adolescents.
da Conceição-Machado, M. E. P., Silva, L., Santana, M. L., Pinto, E. J., Silva, R. D. C. R., Moraes, L. T. L. P., Couto, R., & Assis, A. M. (2013) · Jornal de Pediatria · doi:10.1016/j.jped.2013.02.009 · Cited by 40
Risk Factors Preceding Type 2 Diabetes and Cardiomyopathy
Singh, S., Dhingra, S., Ramdath, D. D., Vasdev, S., Gill, V. D., & Singal, P. K. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9197-3 · Cited by 41
Liu, L., Peng, J., Zang, D., Zhang, Y.-M., Wu, Z., Song, C., Chen, S., Guo, D., Lu, F.-H., Zheng, T.-F., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05665-y · Cited by 38
“High level of plasma triglyceride were regarded as an effective and simple marker for evaluating excess visceral adiposity with a large waistline existing [32, 33].”
BackgroundMaximal Physiological Responses between Aquatic and Land Exercise in Overweight Women
PHILLIPS, V. K., Legge, M., & Jones, L. M. (2008) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318164d0e0 · Cited by 33
“Furthermore, with increased body fat, low levels of cardio protective high density lipoprotein (HDL) are reported (Mansfield, McPherson, & Koski, 1999; Sardinha, Teixeira, Guedes, Going, & Lohman, 2000), in conjunction with elevated low density lipoprotein (LDL) levels (Despres, 1994; Lemieux et al., 2000; Mansfield e…”
BackgroundCardiovascular risk: prevention and treatment of the metabolic syndrome.
Tuomilehto, J. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.03.018 · Cited by 38
Chen, S., Guo, X.-F., Zhang, X.-G., Yu, S.-S., Yang, H.-M., Jiang, M., Sun, G.-Z., & Sun, Y.-X. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0060-y · Cited by 37
“The HtgW phenotype is represented by the simultaneous presence of elevated serum triglyceride levels and an increased waist circumference [13], and this phenotyope is a major determinant of cardiometabolic risk among Turks [14].”
BackgroundBhowmik, B., Afsana, F., Siddiquee, T., Munir, S. B., Sheikh, F., Wright, E., Bhuiyan, F. R., Ashrafuzzaman, S. M., Mahtab, H., Khan, A. K. A., et al. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12268 · Cited by 36
Earnest, C., Mikus, C. R., Lemieux, I., Arsenault, B., & Church, T. (2007) · Nutrition (Burbank, Los Angeles County, Calif.) · doi:10.1016/j.nut.2007.06.003 · Cited by 37
Self-citationThe metabolic syndrome and cardiovascular disease
Bonora, E. (2006) · Annals of Medicine · doi:10.1080/07853890500401234 · Cited by 233
McDonald, S., Maguire, G. P., Duarte, N., Wang, X. L., & Hoy, W. E. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.08.004 · Cited by 37
Fu, S.-H., Luo, L.-M., Ye, P., Liu, Y., Zhu, B., Zheng, J., Bai, Y.-Y., & Bai, J. (2013) · Clinical Interventions in Aging · doi:10.2147/cia.s54352 · Cited by 36
Gao, X., Wang, G., Wang, A.-L., Xu, T., Tong, W., & Zhang, Y.-H. (2013) · Obesity Research and Clinical Practice · doi:10.1016/j.orcp.2012.02.002 · Cited by 36
Arango, C., Bobes, J., Kirkpatrick, B. W., García-García, M., & Rejas, J. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.03.005 · Cited by 34
Janiszewski, P., Ross, R., Despres, J., Lemieux, I., Orlando, G., Carli, F., Bagni, P., Menozzi, M., Zona, S., & Guaraldi, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025032 · Cited by 36
Self-citationEffect of Orlistat on Eating Behavior Among Participants in a 3‐year Weight Maintenance Trial
Svendsen, M., Rissanen, A., Richelsen, B., Rössner, S., Hansson, F., & Tonstad, S. (2008) · Obesity · doi:10.1038/oby.2007.82 · Cited by 38
LDL particle size, fat distribution and insulin resistance in obese children
Miyashita, M., Okada, T., Kuromori, Y., & Harada, K. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602333 · Cited by 36
Metabolomics Profiling of Visceral Adipose Tissue: Results From MESA and the NEO Study
Neeland, I. J., Boone, S. C., Mook‐Kanamori, D. O., Ayers, C. R., Smit, R. A. J., Tzoulaki, I., Karaman, İ., Boulangé, C. L., Vaidya, D. M., Punjabi, N. M., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010810 · Cited by 37
“Using the replicated metabolites, to identify novel VAT-associated metabolites beyond known correlates, we additionally sequentially adjusted for the following: (1) fasting glucose concentrations and waist circumference; and (2) plasma triglyceride concentrations, to investigate if and what metabolites remained after…”
MethodRen, Y.-C., Luo, X., Wang, C.-J., Yin, L., Pang, C., Feng, T., Wang, B.-Y., Zhang, L., Li, L.-L., Yang, X., et al. (2016) · Diabetes/Metabolism Research Reviews · doi:10.1002/dmrr.2725 · Cited by 35
“The concept of HTGW was first proposed as a marker of atherosclerosis in 2000 [1].”
BackgroundObeidat, A. A., Ahmad, M. N., Haddad, F., & Azzeh, F. S. (2015) · PubMed · doi:10.3305/nh.2015.32.2.9063 · Cited by 27
Carlsson, A., Risérus, U., & Ärnlöv, J. (2014) · Obesity · doi:10.1002/oby.20434 · Cited by 35
The role of triglycerides in cardiovascular risk
Gandotra, P., & Miller, M. J. (2008) · Current Cardiology Reports · doi:10.1007/s11886-008-0079-0 · Cited by 33
Genetics of metabolic syndrome: Is there a role for phenomics?
JOY, T. R., & Hegele, R. A. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-008-0032-0 · Cited by 34
Hypertriglyceridemia: A Review of Clinical Relevance and Treatment Options: Focus on Cerivastatin
Breuer, H. (2001) · Current Medical Research and Opinion · doi:10.1185/0300799039117028 · Cited by 35
LeBlanc, S., Coulombe, F., Bertrand, O. F., Bibeau, K., Pibarot, P., Marette, A., Alméras, N., Lemieux, I., Després, J., & Larose, E. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.008139 · Cited by 35
“0 mmol/L and waist circumference ≥90 cm.(13) The identification of the metabolic syndrome was made according to the presence of at least 3 of the following criteria: resting blood pressure ≥130/85 mm Hg, waist circumference ≥102 cm, high-density lipoprotein cholesterol (HDL-C) <1.”
InfluentialSelf-citationChen, S., Guo, X.-F., Dong, S., Yu, S.-S., Chen, Y.-T., Zhang, N.-J., & Sun, Y.-X. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3559-z · Cited by 34
Metadata
- Authors
- Lemieux, I., Pascot, A., Couillard, C., Lamarche, B., Tchernof, A., Alméras, N., Bergeron, J., Gaudet, D., Tremblay, G., Prud’homme, D., Nadeau, A., & Després, J.-P.
- Affiliations
- Centre hospitalier de l'Université Laval (CA)
- From the Quebec Heart Institute, Laval Hospital Research Center; the Lipid Research Center, CHUL Research Center; the Physical Activity Sciences Laboratory, Laval University; the Diabetes Research Unit, CHUL Research Center, Ste-Foy; and the Lipid Clinic, Chicoutimi Hospital, Chicoutimi, Québec, Canada.
- ORCID
- Venue
- Circulation
- Published
- 2000-07-11
- Volume
- 102
- Issue
- 2
- Pages
- 179-184
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1991251155
- Cited by
- 937
- References
- 0
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 23 · 2023: 28 · 2022: 31 · 2021: 29 · 2020: 30 · 2019: 26 · 2018: 35 · 2017: 29 · 2016: 38 · 2015: 38 · 2014: 42 · 2013: 42 · 2012: 49
- FWCI
- 18.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- Heart and Stroke Foundation of Canada
- Medical Research Council Canada
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- hypertriglyceridemic waist phenotype, waist circumference, fasting plasma triglycerides, hyperinsulinemia, apolipoprotein B, small dense LDL, coronary artery disease risk, cardiovascular screening, men
- MeSH terms
- Abdomen, Adult, Apolipoproteins B, Body Composition, Coronary Artery Disease, Coronary Disease, Humans, Hyperinsulinism, Lipoproteins, LDL, Male, Mass Screening, Middle Aged, Predictive Value of Tests, Risk Factors, Triglycerides, Hypertriglyceridemia, Biomarkers, Coronary Angiography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review